04.25.25 -- Innovation In Life Sciences: Human Factors, AI Audits, And CDMO Insights

We know how tough it can be to find the right CDMO, especially when capacity is tight and timelines are critical. That's why we're bringing together 31 CDMOs for our Outsourced Pharma Capacity Update Partners Week — a chance to explore their latest capabilities and available capacity, all from the convenience of your screen. Learn more about our sessions grouped by modality to join us to find the right partner for your project.

Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

Pharmaceutical scientists and engineers must advance robust, sensitive, and efficient nitrosamine detection and control methods to safeguard public health and regulatory compliance.

An assortment of conversations with experienced biopharma executives have generated some surprising commentary about CDMO selection. Chief Editor Louis Garguilo puts those insights together, covering selection preparation/responsibilities, and some interesting CDMO behaviors of late.

Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing.

In this interview, Michael discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

Mandatory nitrosamine testing has driven stricter standards for drug development. Join Cambrex's Todd Sprouse as he shares a stepwise, product-specific approach to detect, quantify, and control nitrosamine impurities efficiently. Key topics include risk evaluation, formation feasibility, analytical method development, and mitigation through targeted testing of materials. Click here to learn more.

Consider the wide breadth of services offered by Grace, including product development, analytical method development, project management, and custom chemical synthesis.

KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

We offer a strategic partnership that enables pharmaceutical companies to leverage specialized expertise and scalable capacities without the need for substantial internal investments.